Can NuScale's Commercial Potential Justify Its Valuation?

NuScale Power Corporation SMR has a credible path toward commercializing its small modular reactor technology, supported by U.S. regulatory approval, supplier readiness and ample liquidity. The opportunity is substantial, but so are the expectations embedded in the stock.

The key question is whether that head start can convert into binding customer agreements and recurring revenues fast enough to justify a valuation that already discounts major future progress.

NuScale Has Built a Meaningful Commercial Head Start

NuScale’s 50-megawatt and 77-megawatt reactor designs have U.S. regulatory approval, while its technology uses commercially available low-enriched uranium. Detailed design work for critical-path components is substantially complete, and agreements are in place with more than half of its network of more than 60 suppliers.

The company ended the second quarter with about $1.9 billion in cash, cash equivalents and short- and long-term investments, giving it room to fund design finalization, fuel-system readiness and supply-chain work ahead of orders. GE Vernova GEV, through GE Vernova Hitachi Nuclear Energy, is advancing the BWRX-300 small modular reactor, while Oklo Inc. OKLO is building an advanced-nuclear platform spanning power, fuel and isotopes, reinforcing how execution is becoming the key differentiator across the sector.

SMR’s Revenue Outlook Requires a Major Step-Up

The Zacks Consensus Estimate projects 2026 revenues of about $33 million and 2027 revenues of about $183 million. That implies a sharp commercial step-up from a business that generated only $0.1 million in second-quarter 2026 revenues after RoPower front-end engineering work ended.

Image Source: Zacks Investment Research

Reaching that 2027 level depends on projects moving into revenue-producing phases. ENTRA1 and the Tennessee Valley Authority are still working toward definitive power purchase agreements, while RoPower requires financing before pre-engineering, procurement and construction work can resume.

NuScale’s Valuation Leaves Little Room for Slippage

SMR trades at 28.6X forward 12-month sales, far above the 4.5X multiple for the Zacks sub-industry. The premium reflects investor willingness to pay for regulatory progress and future commercialization rather than current revenues.

Image Source: Zacks Investment Research

That leaves less room for project delays, financing setbacks or slower-than-expected licensing activity. Until customer agreements convert into sustained engineering, equipment and service revenues, much of the investment case rests on execution that has yet to be demonstrated at scale.

SMR’s Cash Strength Comes at a Dilution Cost

NuScale sold 86.6 million Class A shares during the second quarter for $962.1 million in gross proceeds. Class A shares outstanding rose to about 410.4 million at June 30, 2026, from 318.5 million at year-end 2025.

The balance sheet now provides substantial flexibility, but the funding came at a meaningful ownership cost to existing shareholders. If commercial projects require more capital before recurring customer cash inflows develop, additional equity issuance could create further dilution.

NuScale’s Ranking Supports Patience Over Valuation Chasing

NuScale’s commercial position is stronger than its current revenue base suggests, but the valuation already assumes a sizable portion of that future opportunity. The setup favors watching contract conversion and project financing closely rather than treating regulatory readiness as sufficient proof of commercial success.

SMR currently carries a Zacks Rank #2 (Buy) and a Momentum Score of A, a constructive combination for near-term price action. Yet its Value Score of F, Growth Score of F and VGM Score of F show that the broader style profile remains weak. The ranking supports a favorable near-term view, while the Style Scores reinforce the need for discipline around valuation and execution.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research